Target intelligence / Profile preview

Pathogenic Activated CD8 T Cell (Pathogenic Activated CD8+ T cell)

Target
Pathogenic Activated CD8+ T cell
Molecular classification
T lymphocyte, Cytotoxic T lymphocyte (CTL), Immune cell
01

Overview

A pathogenic activated CD8 T cell refers to a subset of CD8+ cytotoxic T lymphocytes (CTLs) that, upon activation, acquire effector functions and contribute to disease pathology rather than protection. While typical activated CD8+ T cells are essential for immune defense against infected or malignant cells, the "pathogenic" designation implies these cells are involved in tissue damage or autoimmune responses. These cells kill target cells through the release of cytotoxic granules containing perforin and granzymes, engagement of death receptors such as Fas/FasL pathway, and the secretion of pro-inflammatory cytokines like IFN-γ and TNF-α, which can enhance immune responses but also contribute to inflammation and tissue injury if dysregulated. Pathogenic activated CD8+ T cells are implicated in autoimmune diseases, chronic viral infections, and graft-versus-host disease.

Other names
Pathogenic CTLTissue-damaging CD8+ T cellAutoimmune CD8+ T cell
02

Biological functions

CytotoxicityImmune responseInflammationCell killingCytokine production
03

Disease associations

Autoimmune diseasesChronic viral infectionsGraft-versus-host diseaseImmunopathology
04

Safety considerations

Off-target cytotoxicityCytokine release syndromeExacerbation of autoimmunity
05

Biomarkers

PerforinGranzymesFasLIFN-γTNF-α

Beyond the preview

Go deeper on Pathogenic Activated CD8 T Cell (Pathogenic Activated CD8+ T cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic Activated CD8 T Cell (Pathogenic Activated CD8+ T cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call